Australian Public Assessment Report for BNT162b2 (mRNA)

The evaluation of the Comirnaty vaccine was significantly expedited without compromising the TGA’s strict standards of safety, quality and efficacy. This was facilitated through rolling data submission, and through collaboration with international regulators. The provisional determination for the Pfizer-BioNTech COVID-19 vaccine, BNT162b2 (mRNA) was granted by TGA on 14 October 2020.

Facial paralysis: there were 4 reports of facial paralysis (Bell’s palsy) in the vaccine group with none in the placebo group.

42 pages.



If you can spare a few dollars for the creators of this website to continue their research to bring you more great content, any amount, no matter how great or small, would be greatly appreciated.

If you appreciate our work, please click here to make a donation